Naproxen tablets

Form: Tablets

Strength: 250 mg, 375 mg, 500 mg, 550 mg

Reference Brands: Aleve(US); Naprosyn(EU)

Category: Arthritis

Naproxen tablets are approved in the EU and US for pain, inflammation, and rheumatoid arthritis. In the EU, brands like Naprosyn and Anaprox are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on extensive clinical data, with generic versions widely available. Both regions require detailed dossiers for initial approval and continuous pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market access for naproxen tablets, ensuring adherence to European and American standards for safe, effective anti-inflammatory therapy.